Catalog No.
Product Name
Application
Product Information
Citations
-
Purine Nucleoside Analog
2-Methoxy-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. This compound exerts its anticancer effects primarily through the inhibition of DNA synthesis and the induction of apoptosis in malignant cells. It is utilized in research focused on understanding and developing treatments for various lymphoid cancers. -
Purine Nucleoside Analog
8-Bromo-3'-deoxyguanosine is a purine nucleoside analog known for its capacity to inhibit DNA synthesis. Its primary mechanism involves inducing apoptosis, contributing to its antitumor activity, particularly against indolent lymphoid malignancies. This compound is valuable in cancer research for studying cellular responses and therapeutic strategies in oncology. -
Purine Nucleoside Analog
2′-Deoxy-2′-fluoro-4-deoxy-arabinouridine functions as a purine nucleoside analog. It exhibits significant antitumor activity, particularly effective against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for researchers studying cancer therapeutics and cellular response pathways. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-N6,N6-dimethyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for studying the effects of purine metabolism and the therapeutic potential of nucleoside analogs in oncology. -
Purine Nucleoside Analog
2-Chloro-2'-deoxy inosine is a purine nucleoside analog known for its antitumor properties. It effectively targets indolent lymphoid malignancies by inhibiting DNA synthesis and inducing apoptosis in cancer cells. This compound is primarily utilized in research applications focused on cancer biology and the development of therapeutic strategies against lymphoid cancers. -
Nucleoside Metabolite
L-2-Aminoadipate adenylate is a nucleoside metabolite that plays a critical role in amino acid biosynthesis and metabolism. This compound is involved in cellular energy processes and can serve as a substrate in ATP-dependent reactions. Its applications extend to studies in metabolic pathways and the regulation of amino acid availability, making it valuable for research in biochemistry and molecular biology. -
Purine Nucleoside Analog
5’-O-Benzoyl-2’-O,4’-C-methyleneuridine is a purine nucleoside analog that exhibits significant antitumor activity by targeting indolent lymphoid malignancies. Its anticancer mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer therapeutics and the biochemical pathways associated with cell proliferation and survival. -
Purine Nucleoside Analog
3’-O-Acetyl-2’-deoxyuridine is a purine nucleoside analog that interferes with DNA synthesis, offering potential therapeutic avenues in cancer research. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the induction of apoptosis, making it a valuable tool for investigating cancer biology and developing new therapeutic strategies. -
Purine Nucleoside Analog
5-O-Benzoyl-1,2-di-O-isopropylidene-3-keto-alpha-D-xylofuranoside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the promotion of apoptosis. This compound is valuable for researchers investigating targeted therapies in cancer treatment. -
Nucleoside Metabolite
1-Carboxyvinyl carboxyphosphonate is a nucleoside metabolite that acts as a potent inhibitor of various nucleoside-related enzymes. It exhibits significant biological activity in modulating nucleotide metabolism, making it a valuable tool for studying metabolic pathways in cellular function and disease states. This reagent is useful for research applications in nucleoside metabolism and enzyme inhibition assays. -
Adenosine Analog
8-(Methylamino)adenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant vasodilatory effects on smooth muscle and has been demonstrated to possess anti-cancer properties by inhibiting tumor progression. It is utilized in various research applications related to vascular biology and oncology. -
Purine Nucleoside Analog
2'-Deoxy-8-methylthioguanosine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studies focused on therapeutic interventions in hematological cancers and the exploration of nucleoside analogs in chemotherapy. -
Nucleoside Compound
β-D-Ribofuranose analogue 1 is a nucleoside compound that serves as a structural analog of ribofuranose. It is primarily utilized in RNA synthesis, enabling researchers to study RNA-related processes and functions. This compound is essential for applications in nucleic acid research and the development of RNA-based therapeutics. -
Cytidine Analog
3’-O-(2-Methoxyethyl)-5-methylcytidine is a nucleoside analog targeting DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it valuable in cancer research and epigenetic studies. It is particularly useful for investigating the role of DNA methylation in gene regulation and cellular processes. -
Purine Nucleoside Analog
1-(alpha-L-Threofuranosyl)cytosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research and therapeutic applications. This compound is a key tool for studies focused on the mechanisms of nucleoside analogs in cancer treatment strategies. -
Purine Nucleoside Analog
N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)]propylpseudouridine is a purine nucleoside analog primarily targeting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms that include the inhibition of DNA replication and the induction of apoptosis. Its applications in cancer research make it a valuable tool for studying nucleoside analog effects in therapeutic interventions. -
Purine Nucleoside Analog
5'-Protected 2,2'-anhydrouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action primarily involve the inhibition of DNA synthesis and the induction of apoptosis. This compound is an essential tool for research focused on cancer biology and therapeutic development, providing insights into nucleoside metabolism and therapeutic strategies. -
Adenosine Analog
3'-β-C-Ethynyl-N6,N6-dimethyladenosine is an adenosine analog with significant implications in vascular research and oncology. This compound serves as a smooth muscle vasodilator and has demonstrated potential in inhibiting cancer progression. Additionally, it functions as a click chemistry reagent due to its alkyne group, allowing for copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules, making it a valuable tool for bioconjugation and labeling applications in chemical biology. -
Thymidine Analog
2’,3’,5’-Tri-O-benzoyl-5-difluoromethyluridine is a thymidine analog that demonstrates insertional activity within replicated DNA. This compound is valuable for labeling cells and monitoring DNA synthesis, making it an essential tool in molecular biology and genetic research. Its structure enables precise tracking of cellular processes related to DNA replication and repair. -
Purine Nucleoside Analog
2’-β-C-Methyl-6-azauridine is a purine nucleoside analog that exerts its effects primarily through the inhibition of DNA synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the induction of apoptosis, making it a valuable reagent for cancer research and therapeutic studies focused on lymphoid tumors. -
Purine Nucleoside Analog
2’-O-Acetyl-3’-azido-5’-O-(4-methylbenzoyl)-3’-deoxyuridine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, facilitating its efficacy in cancer research. Additionally, this compound serves as a versatile click chemistry reagent due to its azide group, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) with alkyne-containing molecules, DBCO, or BCN groups. This makes it a valuable tool for bioconjugation and molecular labeling studies. -
Coenzyme A Derivative
(25R)-3Alpha,7alpha-dihydroxy-5beta-cholestanoyl-CoA is a coenzyme A derivative that serves as an important substrate in lipid metabolism. Its primary mechanism involves the formation of acyl-CoA thioesters, which play a critical role in fatty acid synthesis and degradation. This compound can be utilized in research focused on lipid biochemistry, metabolic pathway studies, and the regulation of cholesterol homeostasis. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-5-methyl-xylo-uridine is a purine nucleoside analog primarily involved in inhibiting DNA synthesis. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular proliferation. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Guanosine Analog
N2-Phenoxyacetylguanosine is a guanosine analog that targets Toll-like receptor 7 (TLR7). This compound exhibits immunostimulatory activity and has been shown to induce type I interferons in animal models, resulting in antiviral effects. It serves as a valuable tool for research applications focused on viral infections and immune responses. -
Purine Nucleoside Analog
2'-Deoxy-N6-cyclopentyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is utilized in research applications aimed at understanding cancer biology and developing novel therapeutic strategies. -
Purine Nucleoside Analog
7-Methyl wyosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is utilized in research applications focused on cancer therapy and the study of nucleoside interactions within cellular processes. -
Uridine Analog
3’-O-(2-Methoxyethyl) uridine is a uridine analog that primarily targets the uridine metabolic pathway. This compound exhibits potential antiepileptic properties and serves as a valuable tool for researching anticonvulsant and anxiolytic activities. Additionally, it can be utilized in the development of new antihypertensive agents, facilitating advancements in therapeutic applications. -
Guanosine Analog
3,5-Bis-O-(2,4-dichlorobenzyl)guanosine is a guanosine analog targeting Toll-like receptor 7 (TLR7). This compound exhibits immunostimulatory activity, capable of inducing type I interferons and producing antiviral effects in various animal models. It serves as an essential tool for research focused on viral infections and immune response mechanisms. -
Purine Nucleoside Analog
2′-Deoxy-2-iodoadenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications in cancer biology and therapeutic development targeting various malignancies. -
Purine Nucleoside Analog
8-Azaguanosine is a purine nucleoside analog that exhibits significant anticancer activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is utilized in research aimed at understanding and developing targeted therapies for various hematological malignancies. -
Thymidine Analog
5'-O-Benzoylthymidine is a thymidine analog that exhibits insertional activity towards replicated DNA. This compound is utilized in various research applications, including the labeling of cells and tracking of DNA synthesis. Its ability to mimic natural thymidine positions it as a valuable tool for studies in molecular biology and genetics. -
Purine Nucleoside Analog
3’-O-MOE-A(Bz)-2’-CED-phosphoramidite is a purine nucleoside analog that impedes DNA synthesis and induces apoptosis, making it a valuable tool in cancer research. This compound exhibits significant antitumor activity against indolent lymphoid malignancies, facilitating studies on mechanisms of tumor growth inhibition. It is suitable for applications in the development of therapeutic strategies and understanding purine metabolism in cancer cells. -
Purine Nucleoside Analog
3',5'-Di-O-acetylthymidine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its primary mechanisms include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research into cancer therapeutics and the modulation of nucleoside metabolism in cancer cells. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-5-methyluridine is a purine nucleoside analog with potent antitumor activity. This compound primarily targets indolent lymphoid malignancies through mechanisms that include the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable tool for researchers investigating cancer biology and therapeutic strategies in oncology. -
Purine Nucleoside Analog
N2-iso-Butyroyl-2'-fluoro-2'-deoxyarabinoguanosine is a purine nucleoside analog that exerts antitumor activity primarily against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for studying the effects of nucleoside analogs in various cancer models. -
Thymidine Analog
5-Naphthyl-beta-methylaminocarbony-2'-O-methyluridine is a thymidine analog that exhibits insertional activity towards replicated DNA. This compound is valuable for labeling cells and facilitating the tracking of DNA synthesis in various biological research applications. Its structural similarity to thymidine enables its utilization in studies involving nucleic acid metabolism and cellular proliferation. -
Purine Nucleoside Analog
5'-O-DMT-2-thio-2'-dU-3'-phosphoramidite is a purine nucleoside analog that acts as a potent inhibitor of DNA synthesis. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting nucleotide incorporation during DNA replication. This compound is essential for research into cancer therapeutics and the development of novel DNA-targeting strategies. -
Purine Nucleoside Analog
2-Methoxy-2'-deoxy-2'-fluoro-beta-D-arabinoadenosine is a purine nucleoside analogue known for its antitumor properties. This compound exhibits significant activity against indolent lymphoid malignancies, primarily through the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. It is a valuable tool for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
3’-Deoxy-2’-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity. This compound primarily targets indolent lymphoid malignancies through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable reagent for researchers investigating cancer biology and therapeutic strategies targeting nucleoside metabolism. -
Adenosine Analog
N6-(3-Trifluoromethylbenzyl)-2’-C-methyl adenosine is an adenosine analog that primarily acts on adenosine receptors. This compound demonstrates smooth muscle vasodilatory properties and has potential applications in inhibiting cancer progression. Its structural modifications enhance its affinity and selectivity, making it a valuable reagent for research in vascular biology and oncology. -
Purine Nucleoside Analog
6-(2-Furanyl)-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on cancer therapeutics and the study of nucleoside metabolism. -
Purine Nucleoside Analog
5’-Deoxy-5’-(4-morpholinyl)thymidine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly in indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized to explore therapeutic strategies and uncover insights into the molecular mechanisms of tumor growth and response to treatment. -
Purine Nucleoside Analog
2-O-Benzoyl-3-O-t-butyldiphenylsilyl-L-threono lactone is a purine nucleoside analog that demonstrates significant antitumor activity by targeting indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized in studies aimed at understanding its effects on cellular proliferation and tumorigenesis. -
Adenosine Analog
N6,N6-Dimethyl-xylo-adenosine is an adenosine analog with a primary mechanism of action involving modulation of adenosine receptors. This compound has demonstrated significant smooth muscle vasodilator activity and holds potential in inhibiting cancer progression. It is widely utilized in research applications focusing on vascular biology and oncology. -
Uridine Analog
N3-Methyl-2’-O-(2-methoxyethyl)uridine is a uridine analog that acts as a competitive inhibitor of uridine metabolism. This compound exhibits potential antiepileptic properties and is utilized in research to investigate anticonvulsant and anxiolytic activities. Additionally, it is a valuable tool for the development of novel antihypertensive agents. -
Purine Nucleoside Analog
3'-Deoxy-3'-fluoro-5-fluorouridine is a purine nucleoside analog known for its potent antitumor activity. This compound primarily functions by inhibiting DNA synthesis and inducing apoptosis, making it a valuable tool in the study of indolent lymphoid malignancies. Its application in cancer research aids in elucidating mechanisms of tumor cell proliferation and survival, contributing to the development of novel therapeutic strategies. -
Purine Nucleoside Analog
2-Amino-6-chloropurine-9-(2’-O-propargyl)riboside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a click chemistry reagent due to the presence of an alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules, facilitating various bioconjugation applications in chemical biology. -
Purine Nucleoside Analog
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog known for its antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This reagent is suitable for studies focused on nucleoside metabolism and anticancer therapeutics. -
Purine Nucleoside Analog
5’-O-DMTr-3’-deoxyuridine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic studies. This compound can be utilized to investigate the pathways involved in tumor growth and resistance, providing insights into potential treatment strategies. -
Purine Nucleoside Analog
2-Amino-6-chloro-9-(3-deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily mediated through the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer biology and the development of therapeutic strategies targeting nucleic acid metabolism.
